NaviMed Capital, a Washington, DC-based private equity firm focused exclusively on the healthcare industry, closed its third fund, NaviMed Partners III, at $450M.
NaviMed will continue to focus on control investments in fast growing lower middle-market healthcare companies.
NaviMed Capital invests in fast growing lower middle-market healthcare businesses. Its investment strategy focuses on healthcare business process outsourcing and specialty healthcare service providers. It targets profitable private companies with up to $10M of EBITDA and double-digit revenue growth. NaviMed’s senior investment team has a track record of value creation spanning, in the aggregate, dozens of investments and more than $11 Billion of enterprise value created over the course of their combined careers.
Since mid-2021, NaviMed has completed the sale or majority recapitalization of six of its portfolio companies including Argos Health, CenterPointe Behavioral Health System, The CM Group, Lighthouse Lab Services, Lucent Health, and Velocity Clinical Research.
With the new fund, NaviMed now manages more than $850M of capital commitments.
FinSMEs
25/11/2024